NeuBase Therapeutics earnings beat, revenue was in line with estimates
- ByInvesting.com-
Investing.com - NeuBase Therapeutics (NASDAQ:NBSE) (NASDAQ: NBSE) reported first quarter EPS of $-0.275, better than the analyst estimate of $-0.277. Revenue for the quarter came...